Yuan S - Search Results

1

Igniting tumour microenvironment in triple-negative breast cancer using a mannose/hyaluronic acid dual-coated Ganoderma polysaccharide-superparamagnetic iron oxide nanocomplex for combinational therapies.

Yuan S, Zhu L, Luo Y, Chen X, Jing H, Wang J, Su X, Liang M, Zhuang Z. Yuan S, et al. J Drug Target. 2024 Oct 30:1-16. doi: 10.1080/1061186X.2024.2408721. Online ahead of print. J Drug Target. 2024. PMID: 39470031

2

A multicomponent-based microemulsion for boosting ovarian cancer therapy through dual modification with transferrin and SA-R₆H₄.

Zhao H, Chen M, Zhao Z, Zhu L, Yuan S. Zhao H, et al. Among authors: yuan s. Drug Deliv Transl Res. 2021 Oct;11(5):1969-1982. doi: 10.1007/s13346-020-00859-5. Epub 2020 Oct 2. Drug Deliv Transl Res. 2021. PMID: 33006741

3

Effects of monoclonal antibodies against human stathmin combined with paclitaxel on proliferation of the QG-56 human lung carcinoma cell line.

Yuan SF, Chen WJ, Zhu LJ, Zheng WE, Chen H, Xiong JP. Yuan SF, et al. Asian Pac J Cancer Prev. 2012;13(6):2967-71. doi: 10.7314/apjcp.2012.13.6.2967. Asian Pac J Cancer Prev. 2012. PMID: 22938491 Free article.

4

Three-dimensional conformal radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma.

Chen WJ, Yuan SF, Zhu LJ, Sun XN, Zheng W. Chen WJ, et al. J BUON. 2014 Jul-Sep;19(3):692-7. J BUON. 2014. PMID: 25261654 Free article.

5

Ultrasound-microbubbles-mediated microRNA-449a inhibits lung cancer cell growth via the regulation of Notch1.

Meng L, Yuan S, Zhu L, ShangGuan Z, Zhao R. Meng L, et al. Among authors: yuan s. Onco Targets Ther. 2019 Sep 13;12:7437-7450. doi: 10.2147/OTT.S217021. eCollection 2019. Onco Targets Ther. 2019. PMID: 31686849 Free PMC article.

6

Expression of β-tubulin III and survivin in advance stage breast cancer correlates with chemotherapeutic effects of docetaxel.

Yuan SF, Zhu LJ, Zheng WE, Chen H, Wu LL, Zhang W, Sun HY, Chen WJ. Yuan SF, et al. Asian Pac J Cancer Prev. 2012;13(1):361-5. doi: 10.7314/apjcp.2012.13.1.361. Asian Pac J Cancer Prev. 2012. PMID: 22502701 Free article.

7

miR-1251-5p Overexpression Inhibits Proliferation, Migration, and Immune Escape in Clear Cell Renal Cell Carcinoma by Targeting NPTX2.

Yue L, Lin H, Yuan S, Wu L, Chen G, Wang J, Feng J. Yue L, et al. Among authors: yuan s. J Oncol. 2022 Mar 10;2022:3058588. doi: 10.1155/2022/3058588. eCollection 2022. J Oncol. 2022. PMID: 35310907 Free PMC article.

8

Phase II clinical study on the GEMOX regimen as second- line therapy for advanced ovarian cancer.

Yuan SF, Zhang LP, Zhu LJ, Chen WJ, Zheng WE, Xiong JP. Yuan SF, et al. Asian Pac J Cancer Prev. 2013;14(6):3949-53. doi: 10.7314/apjcp.2013.14.6.3949. Asian Pac J Cancer Prev. 2013. PMID: 23886213 Free article. Clinical Trial.

9

SYL3C aptamer-anchored microemulsion co-loading β-elemene and PTX enhances the treatment of colorectal cancer.

Zhou X, Cao C, Li N, Yuan S. Zhou X, et al. Among authors: yuan s. Drug Deliv. 2019 Dec;26(1):886-897. doi: 10.1080/10717544.2019.1660733. Drug Deliv. 2019. PMID: 31524012 Free PMC article.

10

A Magnetic T7 Peptide&AS1411 Aptamer-Modified Microemulsion for Triple Glioma-Targeted Delivery of Shikonin and Docetaxel.

Wang H, Chen W, Wu G, Kong J, Yuan S, Chen L. Wang H, et al. Among authors: yuan s. J Pharm Sci. 2021 Aug;110(8):2946-2954. doi: 10.1016/j.xphs.2021.03.018. Epub 2021 Mar 27. J Pharm Sci. 2021. PMID: 33785350

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,448 results

Search Page

Filters